Department of Neurology, Division of Epilepsy and Clinical Neurophysiology, Children's Hospital Boston, Boston, Massachusetts, USA.
CNS Drugs. 2010 May;24(5):399-430. doi: 10.2165/11310980-000000000-00000.
The newer antiepileptic drugs (AEDs) provide more therapeutic options and overall improved safety and tolerability for patients. To provide the best care, physicians must be familiar with the latest tolerability and safety data. This is particularly true in children, given there are relatively fewer studies examining the effects of AEDs in children compared with adults. Since we now have significant paediatric literature on each of these agents, we provide a comprehensive and current literature review of the newer AEDs, focusing on safety and tolerability data in children and adolescents. Because the safety profiles in children differ from those in adults, familiarity with this literature is important for child neurologists and other paediatric caregivers. We have organized the data by organ system for each AED for easier reference.
新型抗癫痫药物 (AEDs) 为患者提供了更多的治疗选择,整体上提高了安全性和耐受性。为了提供最佳的护理,医生必须熟悉最新的耐受性和安全性数据。在儿童中尤其如此,因为与成年人相比,评估 AED 对儿童影响的研究相对较少。由于我们现在有关于这些药物的大量儿科文献,因此我们对新型 AED 进行了全面和最新的文献综述,重点关注儿童和青少年的安全性和耐受性数据。由于儿童的安全性特征与成人不同,因此熟悉该文献对于儿童神经科医生和其他儿科护理人员很重要。我们按每个 AED 的器官系统组织了数据,以便于参考。
CNS Drugs. 2013-6
Epilepsy Behav. 2019-6-7
Epilepsy Behav. 2017-11
Expert Opin Drug Saf. 2018-9-17
Epilepsy Behav. 2020-2-21
Epilepsia. 2009-2
Eur J Paediatr Neurol. 2009-3
Epilepsy Behav. 2008-1